Legis Daily

Improving Access to Safe Medicines Act of 2022

USA117th CongressHR-8931| House 
| Updated: 11/1/2022
Earl L. "Buddy" Carter

Earl L. "Buddy" Carter

Republican Representative

Georgia

Cosponsors (1)
Deborah K. Ross (Democratic)

Crime and Federal Government Surveillance Subcommittee, Health Subcommittee, Judiciary Committee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Improving Access to Safe Medicines Act of 2022 This bill requires the Drug Enforcement Administration to issue a proposed rule to remove a drug from scheduling under the Controlled Substances Act within 180 days of a recommendation from the Food and Drug Administration to do so.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Sep 21, 2022
Introduced in House
Sep 21, 2022
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sep 22, 2022
Referred to the Subcommittee on Health.
Nov 1, 2022
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
  • September 21, 2022
    Introduced in House


  • September 21, 2022
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • September 22, 2022
    Referred to the Subcommittee on Health.


  • November 1, 2022
    Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.

Crime and Law Enforcement

Improving Access to Safe Medicines Act of 2022

USA117th CongressHR-8931| House 
| Updated: 11/1/2022
Improving Access to Safe Medicines Act of 2022 This bill requires the Drug Enforcement Administration to issue a proposed rule to remove a drug from scheduling under the Controlled Substances Act within 180 days of a recommendation from the Food and Drug Administration to do so.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Sep 21, 2022
Introduced in House
Sep 21, 2022
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sep 22, 2022
Referred to the Subcommittee on Health.
Nov 1, 2022
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
  • September 21, 2022
    Introduced in House


  • September 21, 2022
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • September 22, 2022
    Referred to the Subcommittee on Health.


  • November 1, 2022
    Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Earl L. "Buddy" Carter

Earl L. "Buddy" Carter

Republican Representative

Georgia

Cosponsors (1)
Deborah K. Ross (Democratic)

Crime and Federal Government Surveillance Subcommittee, Health Subcommittee, Judiciary Committee, Energy and Commerce Committee

Crime and Law Enforcement

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted